CJC-1295 (With DAC)

ntroducing CJC-1295 (With DAC) — a modified synthetic growth hormone-releasing hormone (GHRH) analog engineered with Drug Affinity Complex (DAC) technology to extend peptide half-life and prolong activity in research settings.

Widely utilized in endocrine and metabolic research, CJC-1295 with DAC has been studied for its sustained stimulation of natural growth hormone release and long-acting signaling properties.

Key Characteristics

• Synthetic GHRH analog with DAC technology
• Extended half-life for prolonged research activity
• Research-grade lyophilized peptide formulation
• Commonly investigated for sustained GH release dynamics
• Designed for controlled laboratory and investigational use

Research Applications

CJC-1295 (With DAC) has been explored in studies involving:

• Long-acting growth hormone secretion pathways
• Recovery and regenerative signaling research
• Lean tissue and protein synthesis investigations
• Metabolic and endocrine regulation studies
• Sleep, recovery, and hormonal rhythm analysis
• Healthy aging and performance physiology research

Product Format

• Sterile sealed peptide vial
• Clearly labeled for laboratory identification
• Intended exclusively for research purposes
• Suitable for professional investigational environments

Storage Guidance

Store refrigerated and protected from light, heat, and moisture. Reconstituted solutions should be maintained according to accepted laboratory handling standards.

Research Use Only — Not intended for human consumption, medical treatment, or veterinary use.